Michael Gibson Journalist Profile

Articles

AI in Quantitative CT Assessments: CONFIRM2 with Dr Alexander Van Rosendael

Nov 6, 2024 | radcliffecardiology.com | Alexander Van Rosendael |Dipti Itchhaporia |Michael Gibson

In this episode of the "Innovations in Cardiology" series, host Dr Dipti Itchhaporia (Hoag Heart and Vascular Institute, Newport Beach, CA, US) is joined by Dr Alexander Van Rosendael (Leiden University Medical Center, Leiden, NL) to discuss the findings from the CONFIRM2 trial.
Insights in Cardiovascular Innovation and Research: A Conversation with Dr Michael Gibson

Oct 14, 2024 | radcliffecardiology.com | Michael Gibson |Dipti Itchhaporia |Mark Mills |Peter Calvert

In this episode of the "Innovations in Cardiology" series, host Dr Dipti Itchhaporia, former president of the ACC, is joined by Dr C. Michael Gibson, CEO of the Baim Institute for Research, for an insightful discussion on the latest advancements and future directions in cardiovascular innovation for 2024. Dr Itchhaporia and Dr Gibson explore strategies to enhance efficiency in cardiovascular research, with a focus on direct-to-patient trials.
The Scent of Bright Light

Aug 9, 2024 | pres-outlook.org | Michael Gibson

Jean DudekResource Publications, 164 pagesPublished January 26, 2024Jean Dudek’s novel The Scent of Bright Light tackles a foundational tale of Islam, Christianity, and Judaism – the account of Abraham, Ishmael, and Isaac – breathing life into two other key players of this ancient drama, Sarah and Hagar. Dudek maintains strict fidelity to the biblical account, revealing her mastery of the hermeneutic spin each faith tradition gives to this story.
ACC 24 Late-Breaker Discussion: The AEGIS-II Trial

Apr 6, 2024 | uscjournal.com | Harriette Van Spall |Michael Gibson |Joost Daemen |Anne W. Alexandrov

ACC 2024 — Late-breaker host, Dr Harriette Van Spall and Principal Investigator, Dr C Michael Gibson discuss the AEGIS-II trial (CSL Behring) (NCT03473223). This phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study investigated the efficacy and safety of an apolipoprotein A-I (apoA-I), CSL112 in patients with acute coronary syndrome (ACS). Investigators enrolled 18200 participants.
Can You Legally Shoot a Trespasser in the State of Texas?

Jul 17, 2023 | ksfa860.com | Michael Gibson

Today's topic can be a sticky discussion for some. How far can you go to protect what is yours? For some, its a simple answer, I can go to whatever lengths to protect my property. For others, they don't want to take matters into their own hands and let the police handle the situation. Either way, there are legal stipulations to handling the defending of your property whether it's your plot of land, your home or even your vehicle when it's parked in your driveway.
A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinoma

Jul 4, 2023 | acsjournals.onlinelibrary.wiley.com | Shetal A. Patel |Michael Gibson |Allison M. Deal |Siddharth Sheth

Abstract Background Patients with locally advanced head and neck squamous cell cancer (HNSCC) are treated with surgery followed by adjuvant (chemo) radiotherapy or definitive chemoradiation, but recurrence rates are high. Immune checkpoint blockade improves survival in patients with recurrent/metastatic HNSCC; however, the role of chemo-immunotherapy in the curative setting is not established.
Today I Take a Look at the Law Around Defending Your Property in Texas

May 5, 2023 | kicks105.com | Michael Gibson

Today's topic can be a sticky discussion for some. How far can you go to protect what is yours? For some, its a simple answer, I can go to whatever lengths to protect my property. For others, they don't want to take matters into their own hands and let the police handle the situation. Either way, there are legal stipulations to handling the defending of your property whether its your plot of land, your home or even your vehicle when it's parked in your driveway.